Navigation Links
Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?'
Date:7/31/2008

Arlington, VAA federal decision to permit the State of Michigan to spray the state's apple orchards with gentamicin risks undermining the value of this important antibiotic to treat blood infections in newborns and other serious human infections, according to the Infectious Diseases Society of America (IDSA).

The Environmental Protection Agency (EPA) on Wednesday granted the state of Michigan "emergency" permission to use gentamicin to fight a tree disease called fire blight.

"At a time when bacteria are becoming increasingly resistant to many of our best antibiotics, it is an extremely bad idea to risk undermining gentamicin's effectiveness for treating human disease by using it to treat a disease in apples," said IDSA President Donald Poretz, MD.

Gentamicin is a crucial antibiotic used to treat dangerous gastrointestinal and urinary tract infections, and is particularly valuable for treating blood infections in newborn children. As rates of antibiotic-resistant infections rise across the country, effective drugs like gentamicin become increasingly valuable. The Food and Drug Administration classifies gentamicin as, "highly important." The Environmental Protection Agency (EPA) currently bans its use on imported fruits and vegetables and EPA officials have previously stated that using gentamicin in agriculture could reduce its value in treating human infections.

But in an ill-advised reversal, EPA granted Michigan special permission to use the antibiotic. The reason, ironically, is that fire blight has become resistant to the antibiotic apple growers had been using, streptomycin.

Microbes evolve resistance quickly, whether they cause human disease or apple disease. What worries infectious diseases physicians is that microbes pass those resistance traits on to other microbes. So when some species of microbe inevitably evolves resistance to gentamicin, IDSA is very concerned that that trait will show up in bacteria
'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
3. Psychiatrists are the least religious of all physicians
4. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
5. Scientists, physicians present latest findings in personalized cancer treatment and prevention
6. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
7. U.S. Physicians Question Presidential Candidates
8. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
9. Internal medicine physicians recommend key elements to guide state initiatives
10. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
11. American College of Physicians publishes The Fenway Guide to LGBT Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Autism is no stranger to the children of ... is access to clinical services, including reliable diagnosis and ... example, validated for use in Swahili, a major language ... researchers at Brown University and the University of Georgia ... implemented at two sites in the country and found ...
(Date:9/30/2014)... NJ (PRWEB) September 30, 2014 ... and wellness, is opening another new medical specialty practice ... IMA Cardiology will be located within the ... Ziad Abbud and Dr. Isaac Tawfik of American Heart ... N.J. The new practice will offer Integrated Medicine Alliance ...
(Date:9/30/2014)... Glycodrive , one of the newest ... maximize lean, strong muscle growth with a proprietary blend ... has caught the attention of Shane Michaels, prompting an ... is to help the body use carbohydrates in a ... essential in the muscle-building process, and Glycodrive makes them ...
(Date:9/30/2014)... VisitandCare.com reports that revenue ... up more than 79 percent in 2014, marking five ... reported total revenue tripled for its entirety of partnered ... strategy has allowed them to partner with plastic ... comfort and privacy — with state-of-the-art surgical atmospheres aimed ...
(Date:9/30/2014)... September 30, 2014 A group of Americans ... combat an epidemic that, left unchecked, could create a catastrophic, ... not headed to Africa. John Rogers, the Executive Director the ... Korea to fight a disease most think mankind conquered long ... 80 years ago is on the comeback in several countries ...
Breaking Medicine News(10 mins):Health News:New diagnostic approach for autism in Tanzania 2Health News:New diagnostic approach for autism in Tanzania 3Health News:New diagnostic approach for autism in Tanzania 4Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... ... infrastructure for Policy, Compliance, Risk, SOX, Internal Audits and IT Governance programs for ... ... (“MetricStream”), the market leader in the enterprise-wide Governance, Risk and Compliance ...
... ... Italy is First in Europe to Treat Neovascular AMD Patients with New Epimacular Brachytherapy ... Fremont, ... the first European patients have been treated following the commercialization of the VIDON® ANV® ...
... 12 ULURU Inc. (NYSE Alternext: ULU), ... a portfolio of wound management and oral care products, today ... shares of its common stock at a price per share ... investors, resulting in gross proceeds of approximately $1.5 million. , ...
... Zimmer Holdings, Inc. (NYSE: ZMH ... Securities and Exchange Commission an automatic shelf registration statement on Form ... equity and debt securities and that it intends, subject to market ... benchmark size. , The Company intends to use the net ...
... Pharmaceuticals, a pioneer in the development of novel products ... disease, has announced that it has filed its first ... and Drug Administration (FDA). CEQ508, an orally administered ... oncogene implicated in the formation of colonic polyps and ...
... PARI Respiratory Equipment launched a newly ... Efficient Aerosol Delivery, rounding out their free learning ... case managers, and pharmacists. The updated class ... for caregivers to update their skills and receive ...
Cached Medicine News:Health News:Amedisys Selects MetricStream for Integrated Enterprise-wide GRC 2Health News:NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization 2Health News:NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization 3Health News:ULURU Inc. to Raise $1.5 Million in Registered Direct Offering 2Health News:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Health News:Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology 2Health News:Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology 3Health News:Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology 4Health News:PARI Respiratory Equipment Offers New Respiratory Management Course 2
(Date:9/30/2014)... , Sept. 30, 2014  Based on ... market, Frost & Sullivan recognizes Ventana Medical Systems, ... with the 2014 North American Frost & Sullivan ... quality practices along with a focus on innovation ... global leader in tissue-based cancer diagnostic solutions for ...
(Date:9/30/2014)... YORK , Sept. 30, 2014  Proteomics ... according to a new report from Kalorama Information.  The ... deals had occurred in proteomics in the past ... IPOs, to agreements between private proteomic companies and ... companies with novel proteomics innovator companies.  Kalorama observed ...
(Date:9/30/2014)... Sept. 30, 2014   Decision Resources Group ... data, anemic chronic kidney disease non-dialysis (CKD-ND) patients ... (ESA) medication. In addition, one-year persistency is similar ... Other key findings from the report entitled ... of Erythropoiesis Stimulating Agents in Late Stage Chronic ...
Breaking Medicine Technology:Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3
... 2 60-ms bursts of 50 Hz separated by .75 ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz (100 ... Output Current: Adjustable from 0-70 mA , Stimulus ... Battery LED (green) indicates that the units on; it ...
Anesthesia Associates Nerve Stimulator Model AA 1050...
... newest peripheral nerve stimulator from B. Braun Medical. ... providing advanced digital technology. , ,Your ability ... allows the localization of practically all mixed nerves ... ,An additional optional component for the HNS11 is ...
... original MS-III design the new ... keypad and battery ... MS-IV peripheral nerve stimulator can ... in operating room, post anesthesia ...
Medicine Products: